As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are targeting the next goalpost: a cure.

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this ...

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this wily, shape-shifting amoeba causes nothing worse than diarrhea.

The single-celled parasite Entamoeba histolytica infects 50 million people each year, killing nearly 70,000. Usually, this ...

With other pathogens, like HIV and salmonella ... They advocate for combining this with the gene-editing tool CRISPR. Using this approach, they could label proteins with fluorescent markers ...

Bird Flu Outbreak Easing In California: The worst of the H5N1 avian flu outbreak — which began in 2024 and infected thousands of birds and dairy cows and dozens of people in the U.S. — may be over in ...

With other pathogens, like HIV and salmonella ... They advocate for combining this with the gene-editing tool CRISPR. Using this approach, they could label proteins with fluorescent markers ...